Business Context and Reporting Period
This Form 8-K filing by Q/C Technologies, Inc. (QCLS) covers events occurring between September 30, 2025, and October 3, 2025. The report details amendments to a recent private placement, the entry into a new consulting agreement, and the grant of equity compensation to directors and officers.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The document focuses exclusively on corporate governance, capital structure modifications, and contractual agreements.
Material Changes and Agreements
- Amendment to Private Placement: On September 30, 2025, the Company entered into an Omnibus Waiver and Amendment regarding its September 2025 private placement of Series H Convertible Preferred Stock. Key changes include:
- Amended the definition of "Excluded Securities" to allow the issuance of up to 15.0% of the sum of outstanding common stock and convertible preferred stock shares under an Approved Stock Plan.
- Accelerated the deadline to file the Registration Statement with the SEC to 30 calendar days following the Closing Date (September 4, 2025).
- Waived prohibitions on issuing warrants to consultants and registering certain securities.
- Consulting Agreement: On October 1, 2025, the Company signed a two-year agreement with James Altucher and Z-List Media, Inc. for services including fundraising, crypto portfolio management, and investor relations.
- Compensation includes warrants to purchase up to 400,000 shares of Common Stock issued in four tranches.
- Exercise prices range from $5.00 to $10.00 per share depending on the tranche.
- Equity Grants: On October 3, 2025, the Board granted an aggregate of 200,000 Restricted Stock Units (RSUs) to six directors and officers.
- Approximately 108,644 RSUs vested immediately.
- Approximately 91,356 RSUs are contingent upon stockholder approval of an increase in shares reserved under the 2021 Equity Incentive Plan.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, revenue outlook, or management commentary regarding future operational performance. The primary risks and contingencies identified are:
- Dilution Risk: The issuance of 400,000 consultant warrants and 200,000 RSUs, along with the amendment allowing for additional stock plan issuances, may dilute existing shareholders.
- Regulatory Compliance: The Company must file the Registration Statement within the accelerated 30-day window to comply with the amended Registration Rights Agreement.
- Contingent Vesting: A portion of the recent RSU grants is contingent on stockholder approval of a plan amendment.
Investor Verification Checklist
- Verify the filing status and effective date of the Registration Statement required by the amended Registration Rights Agreement.
- Review the full text of the Omnibus Waiver and Amendment (Exhibit 10.1) to understand the specific scope of the "Excluded Securities" modification.
- Confirm the terms and vesting schedules of the Consultant Warrants issued to James Altucher and Z-List Media (Exhibit 4.1).
- Monitor upcoming stockholder meetings for the vote required to approve the increase in shares reserved under the 2021 Equity Incentive Plan.
- Assess the impact of the new equity grants on the Company's fully diluted share count.